Reaching the €100 million quantum investment milestone, Novo Holdings looks to expand globally and merge healthcare.
Nova investments
The Novo Nordisk Foundation’s investment firm, Novo Holdings, has published its 2025 Quantum Investments Annual Review. The evaluation notes that the company’s dedicated quantum investment portfolio has expanded quickly to reach about €100 million, demonstrating significant progress in its commitment to quantum technology.
Also Read About Amazon Braket Notebooks support CUDA-Q NVIDIA for HQC
Rapid Portfolio Growth and Long-Term Commitment
The announcement explains that the €100 million ($145.5 million USD) portfolio result is a noteworthy first-year achievement after Novo Holdings’ specialized quantum team was launched in 2024. This early accomplishment is a precursor to the company’s considerably larger long-term commitment to developing quantum technology, which is valued at DKK 1.4 billion (€188 million, or $217.1 million USD).
The main goal of Novo Holdings’ strategy is to hasten the creation of a competitive European quantum ecosystem. The team’s quick start in its first year of business, successfully creating a balanced portfolio and cultivating crucial relationships, was recognised by Jeroen Bakker, Partner, Novo Holdings Quantum Investments.
Also Read About Top Swiss Startups 2025: Quantum QFX, Y-Quantum And Zuriq
Strategic Dual Focus: Health and the Green Transition
The investment strategy has two main focusses. The strategy’s first pillar consists of direct investments aimed at applications particularly associated with the green transformation and healthcare. This strategy is in line with the overarching goal of the Novo Nordisk Foundation, which is to develop quantum technologies to solve pressing issues pertaining to the health of people and the world.
The strategy’s second prong consists of fund investments, which are used to increase Novo Holdings’ exposure to the global quantum stack. Although Denmark serves as the initiative’s cornerstone, the fund’s overall view is still worldwide.
Also Read About Quantum Pulse Ventures QPV For Photonic Quantum Computers
Diversifying Across the Quantum Stack
Currently, the extensive portfolio covers important domains in the quantum industry, including as software, hardware, and specialised venture capital.
Novo Holdings has made direct investments in a number of innovative businesses, including:
- Sparrow Quantum: This Danish business focusses on deterministic photonic chips.
- Phasecraft is a UK-based company that specializes in creating essential quantum algorithms for the fields of materials science, energy, and biology. Novo Holdings has made significant investments in the intersection of quantum technology with artificial intelligence and the biological sciences.
In order to guarantee extensive global exposure to a range of quantum technologies, Novo Holdings has additionally undertaken sizeable fund investments:
- Novo Holdings is a major investor in this Danish quantum venture fund located at 55 North (Denmark).
- Quantonation II (France): Through a specialized quantum venture capital fund, this investment offers exposure.
- Playground Global IV (US): This pledge is linked to an investment in a US-based deep-tech fund.
Transitioning to the ‘Megaquop’ Era
According to Novo Holdings, the field of quantum computing is currently emerging from the constrained NISQ (Noisy Intermediate-Scale Quantum) stage. According to the strategic effort, quantum is now moving into the “megaquop” age, which is defined by the shift towards more sophisticated systems with logical qubits and error correction.
Novo Holdings has set certain growth goals for the future. Along with a number of fund holdings, the organisation wants to create a consolidated portfolio of eight to ten direct investments. By 2030, this major extension is expected to be finished.
The Novo Nordisk Foundation’s sole proprietor and investment management firm is Novo Holdings. The organization’s commitment to promoting deep-tech innovation and aiding in the creation of crucial next-generation technologies is further cemented with the release of the Quantum Investments Annual Review 2025.
Also Read About IonQ and UChicago Announce Strategic Partnership for Quantum
